
Park Medi World IPO
- Issue price
- ₹162
- Listing price
- ₹158.8
- -1.98%
- Current price
- ₹255.58
- +57.77%
- Subscribed
- 8.1x
- Issue size
- ₹920 Cr
- Listed on
- 17 Dec 2025
IPO timeline
- Opens10 DecWed
- Closes12 DecFri
- Allotment16 DecTue
- Refunds16 DecTue
- Demat credit16 DecTue
- Listing17 DecWed
Issue details
- Price band
- ₹154 – ₹162 per share
- Issue size
- ₹920 Cr
- Fresh issue
- Not available
- Offer for sale
- Not available
- Issue type
- Fresh capital cum OFS
- Face value
- ₹2 per share
- Lot size
- 92 shares
- Minimum investment
- ₹14,904
- Listing on
- BSE & NSE
- Exchange code
- PARKHOSPS · 7493
This issue combines a fresh issue and an offer for sale. The amounts for each part are not available in our data; see the offer document for the split.
Lot size and investment
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 92 | ₹14,904 |
| Retail (Max) | 13 | 1,196 | ₹1,93,752 |
| S-HNI (Min) | 14 | 1,288 | ₹2,08,656 |
| B-HNI (Min) | 68 | 6,256 | ₹10,13,472 |
Reservation
- QIB
- 2,83,95,060 shares (50.00% of the Offer)
- NII
- 85,18,519 shares (15.00% of the Offer)
- Retail
- 1,98,76,544 shares (35.00% of the Offer)
Allotment status
The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).
Check allotment on KFin Technologies- 1Open the registrar's allotment page and select this IPO from the list.
- 2Enter your PAN, application number or DP / Client ID.
- 3Submit to see the number of shares allotted, if any.
- Basis of allotment
- 16 Dec 2025
- Refunds initiated
- 16 Dec 2025
- Shares credited to demat
- 16 Dec 2025
- Listing
- 17 Dec 2025
Grey market premium (GMP)
- Current GMP
- ₹30
- +19.00%
- Estimated listing price
- ₹192
- Issue price ₹162
- Kostak rate
- ₹0
GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.
Subscription status
- QIB11.48x
- NII (HNI)15.15x
- Retail3.16x
| Category | Shares offered | Shares bid for | Subscribed |
|---|---|---|---|
| Qualified Institutional Buyers (QIB) | 1,19,48,052 | 13,71,09,808 | 11.48x |
| Non-Institutional Investors (NII) | 89,61,039 | 13,57,18,492 | 15.15x |
| bNII — bids above ₹10 Lakh | 59,74,026 | 10,41,55,592 | 17.43x |
| sNII — bids ₹2 Lakh to ₹10 Lakh | 29,87,013 | 3,15,62,900 | 10.57x |
| Retail Individual Investors (RII) | 2,09,09,091 | 6,60,02,272 | 3.16x |
| Total | 4,18,18,182 | 33,88,30,572 | 8.1x |
Financials
- P/E Ratio
- 63.52
- EPS (₹)
- 7.24
- RoCE
- 18.67
- RoNW
- 13.19
- PAT Margin
- 8.88
Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.
| Period ended | 30 sep 25 | 31 mar 25 | 31 mar 24 |
|---|---|---|---|
| Revenue | 483.97 | 769.92 | 574.72 |
| OPM % | 23.16 | 10.73 | 12.57 |
| EBITDA | 110.31 | 166.64 | 99.66 |
| Net Profit | 14.23 | 67.10 | 35.13 |
| Debt | 207.04 | 225.80 | 243.37 |
| Assets | 1,193.68 | 996.46 | 806.02 |
Peer comparison
| Company | Issue size | P/E | RoNW | PAT margin | Subscribed | Listing gain |
|---|---|---|---|---|---|---|
| Park Medi World This IPO | ₹920 Cr | 63.52 | 13.19% | 8.88% | 8.1x | -1.98% |
| Molbio Diagnostics Mainboard · listed 17 Aug 2026 | ₹939.7 Cr | 56.67 | 14.55% | 11.28% | 70.26x | +21.44% |
| Sudeep Pharma Mainboard · listed 28 Nov 2025 | ₹895 Cr | 53.55 | 27.88% | 27.63% | 93.72x | +23.10% |
| Nephrocare Health Services Mainboard · listed 17 Dec 2025 | ₹871.05 Cr | 162.19 | 13.19% | 8.88% | 13.96x | +6.52% |
| Ellenbarrie Industrial Gases Mainboard · listed 1 Jul 2025 | ₹852.53 Cr | 67.69 | 24.97% | 23.90% | 22.47x | +21.50% |
| Suraksha Diagnostic Mainboard · listed 6 Dec 2024 | ₹846.25 Cr | 74.89 | 14.09% | 10.57% | 1.27x | -0.68% |
| Medi Assist Healthcare Services Mainboard · listed 23 Jan 2024 | ₹1,171.58 Cr | 31.8 | 19.63% | 14.51% | 16.25x | +10.05% |
Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.
IPO objectives
How Park Medi World plans to use the money raised, as stated in the offer document.
- BRLMs’ fees and commissions (including underwriting commission, brokerage and selling commission)₹38 Cr
- Commission/processing fee for SCSBs and Bankers to the Offer and fees payable to the Sponsor Banks for Bids made by UPI Bidders, brokerage, selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs₹3.12 Cr
- Fees payable to the Registrar to the Offer₹0.08 Cr
- Fees payable to advisors, consultants and other parties to the Offer
- Auditors₹0.53 Cr
- Industry expert₹0.83 Cr
- Fee payable to legal counsel₹8.74 Cr
- Listing fees, SEBI filing fees, upload fees, BSE and NSE processing fees, book building software fees and other regulatory expenses₹3.47 Cr
- Printing and stationery₹1.17 Cr
- Advertising and marketing expenses₹6.89 Cr
- Miscellaneous₹4.93 Cr
- othres
About Park Medi World
Park Medi World is an India-based healthcare company engaged in providing a range of medical products and services to hospitals, clinics, and healthcare institutions. The company was established with the objective of improving accessibility to quality medical supplies and healthcare solutions. Over the years, it has built a presence in the healthcare distribution space by focusing on reliability, timely delivery, and strong vendor relationships. The promoters bring industry experience and have played a key role in expanding the company’s operations and strengthening its network across multiple regions. The company offers a diversified portfolio that includes medical consumables, surgical instruments, diagnostic products, and other healthcare-related supplies. Its business model is largely based on sourcing products from manufacturers and supplying them to institutional clients, ensuring consistent demand and repeat business. Park Medi World focuses on maintaining quality standards and competitive pricing to serve its clients efficiently. By leveraging its distribution network and industry connections, the company aims to achieve steady growth and expand its footprint in the Indian healthcare sector.
Promoters and shareholding
Ajit Gupta, Ankit Gupta
- Promoter holding, pre-issue
- 95.55%
- Promoter holding, post-issue
- 82.89%
Registrar, lead managers and documents
Company contact
Nephrocare Health Services Ltd. Address 5 th Floor, D Block, iLabs Centre, Plot 18, Software Units Layout, Survey No. 64, Madhapur, Shaikpet, Hyderabad, Telangana, 500081
+91 40 4240 8039
cs@nephroplus.comPark Medi World IPO: common questions
1.When does the Park Medi World IPO open and close?
The Park Medi World IPO opens on 10 Dec 2025 and closes on 12 Dec 2025.
2.What is the price band of the Park Medi World IPO?
The price band is ₹154 – ₹162 per share, with a lot size of 92 shares and a minimum investment of ₹14,904.
3.What is the size of the Park Medi World IPO?
The issue size is ₹920 Cr (Fresh capital cum OFS).
4.What is the GMP of the Park Medi World IPO?
The last reported grey market premium is ₹30 per share as of 06 Dec 2025, 12:00 PM IST. GMP is unofficial and changes frequently.
5.When is the Park Medi World IPO allotment?
The basis of allotment is expected on 16 Dec 2025. Allotment status can be checked with the registrar, KFin Technologies Limited.
6.When will the Park Medi World IPO list?
The shares listed on 17 Dec 2025 on BSE & NSE.
7.Who is the lead manager of the Park Medi World IPO?
The book running lead managers are Nuvama Wealth Management Ltd., Dam Capital Advisors Ltd, and the registrar is KFin Technologies Limited.
8.What will the money raised in the Park Medi World IPO be used for?
As stated in the offer document, the proceeds are for: BRLMs’ fees and commissions (including underwriting commission, brokerage and selling commission); Commission/processing fee for SCSBs and Bankers to the Offer and fees payable to the Sponsor Banks for Bids made by UPI Bidders, brokerage, selling commission and bidding charges for Members of the Syndicate, Registered Brokers, RTAs and CDPs; Fees payable to the Registrar to the Offer; Fees payable to advisors, consultants and other parties to the Offer; Auditors.
9.How can my company launch an IPO like Park Medi World?
Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.
For business owners
Your company could be the next listing
Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.
- Eligibility check against NSE Emerge, BSE SME and Main Board norms
- Indicative valuation and issue size for your business
- A clear timeline from readiness to listing day
Check if your business can list
Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.
Prefer to talk? Call +91 92130 20393